Aron M. Knickerbocker
2018
Compensation breakdown
Non-Equity Incentive Plan | $225,000 |
---|---|
Option Awards | $1,073,484 |
Salary | $500,000 |
Stock Awards | $280,350 |
Other | $6,072 |
Total | $2,084,906 |
Knickerbocker received $1.1M in option awards, accounting for 51% of the total pay in 2018.
Knickerbocker also received $225K in non-equity incentive plan, $500K in salary, $280.4K in stock awards and $6.1K in other compensation.
Rankings
In 2018, Aron M. Knickerbocker's compensation ranked 5,512th out of 14,244 executives tracked by ExecPay. In other words, Knickerbocker earned more than 61.3% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 5,512 | 61st |
Manufacturing | 2,078 | 64th |
Chemicals And Allied Products | 767 | 64th |
Drugs | 642 | 65th |
Pharmaceutical Preparations | 495 | 64th |
Pay ratio
Aron M. Knickerbocker's Pay | $2,084,906 |
---|---|
Median Employee's Pay | $201,670 |
Pay Ratio | 10to 1 |
In 2018, the annual total compensation of Aron M. Knickerbocker was $2,084,906.
The annual total compensation of the median employee at Five Prime Therapeutics was $201,670.
The ratio of Aron M. Knickerbocker's pay to the pay of median employee was therefore 10 to one.
Knickerbocker's colleagues
We found six more compensation records of executives who worked with Aron M. Knickerbocker at Five Prime Therapeutics in 2018.
2018
David Smith
Five Prime Therapeutics
Chief Financial Officer
2018
Bryan Irving
Five Prime Therapeutics
Chief Scientific Officer
2018
Helen Collins
Five Prime Therapeutics
Chief Medical Officer
2018
Francis Sarena
Five Prime Therapeutics
Secretary
2018
Linda Rubinstein
Five Prime Therapeutics
Chief Financial Officer
2018
Marc Belsky
Five Prime Therapeutics